Regional citrate anticoagulation for continuous renal replacement therapy in newborns
BackgroundRegional citrate anticoagulant (RCA) is recommended as the preferred anticoagulant regimen for continuous renal replacement therapy (CRRT) in adults; however, it is rarely reported in neonates due to concerns associated with their immature liver. Few studies have reported on the use of RCA...
Saved in:
Main Authors: | Haixia Huang (Author), Xing Deng (Author), Ke Bai (Author), Chengjun Liu (Author), Feng Xu (Author), Hongxing Dang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
by: Yuelin Sun, et al.
Published: (2023) -
Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
by: Fang Hu, et al.
Published: (2022) -
Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure
by: Jun Hu, et al.
Published: (2023) -
Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023) -
Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study
by: Ying Yu, et al.
Published: (2018)